Copyright Reports & Markets. All rights reserved.

Global Eosinophilic Esophagitis Drug Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Eosinophilic Esophagitis Drug Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type
    • 1.2.2 Budesonide
    • 1.2.3 Fluticasone
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Application
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Drugstore
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Eosinophilic Esophagitis Drug Market Size Estimates and Forecasts
    • 2.1.1 Global Eosinophilic Esophagitis Drug Revenue 2015-2026
    • 2.1.2 Global Eosinophilic Esophagitis Drug Sales 2015-2026
  • 2.2 Eosinophilic Esophagitis Drug Market Size by Region: 2020 Versus 2026
  • 2.3 Eosinophilic Esophagitis Drug Sales by Region (2015-2026)
    • 2.3.1 Global Eosinophilic Esophagitis Drug Sales by Region: 2015-2020
    • 2.3.2 Global Eosinophilic Esophagitis Drug Sales Forecast by Region (2021-2026)
    • 2.3.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2015-2026)
  • 2.4 Eosinophilic Esophagitis Drug Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Eosinophilic Esophagitis Drug Revenue by Region: 2015-2020
    • 2.4.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2021-2026)
    • 2.4.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2015-2026)

3 Global Eosinophilic Esophagitis Drug by Manufacturers

  • 3.1 Global Top Eosinophilic Esophagitis Drug Manufacturers by Sales
    • 3.1.1 Global Eosinophilic Esophagitis Drug Sales by Manufacturer (2015-2020)
    • 3.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Manufacturer (2015-2019)
  • 3.2 Global Top Eosinophilic Esophagitis Drug Manufacturers by Revenue
    • 3.2.1 Global Eosinophilic Esophagitis Drug Revenue by Manufacturer (2015-2020)
    • 3.2.2 Global Eosinophilic Esophagitis Drug Revenue Share by Manufacturer (2015-2020)
  • 3.3 Global Eosinophilic Esophagitis Drug Price by Manufacturer (2015-2020)
  • 3.4 Competitive Landscape
    • 3.4.1 Key Eosinophilic Esophagitis Drug Manufacturers Covered: Ranking by Revenue
    • 3.4.2 Global Eosinophilic Esophagitis Drug Market Concentration Ratio (CR5 and HHI) & (2015-2020)
    • 3.4.3 Global Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.5 Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution, Product Type
    • 3.5.1 Eosinophilic Esophagitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.5.2 Manufacturers Eosinophilic Esophagitis Drug Product Type
    • 3.5.3 Date of International Manufacturers Enter into Eosinophilic Esophagitis Drug Market
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

  • 4.1 AstraZeneca
    • 4.1.1 AstraZeneca Corporation Information
    • 4.1.2 AstraZeneca Description, Business Overview
    • 4.1.3 AstraZeneca Eosinophilic Esophagitis Drug Products Offered
    • 4.1.4 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
    • 4.1.5 AstraZeneca Eosinophilic Esophagitis Drug Revenue by Product
    • 4.1.6 AstraZeneca Eosinophilic Esophagitis Drug Revenue by Application
    • 4.1.7 AstraZeneca Eosinophilic Esophagitis Drug Revenue by Geographic Area
    • 4.1.8 AstraZeneca Eosinophilic Esophagitis Drug Revenue by Sales Channel
    • 4.1.9 AstraZeneca Recent Development
  • 4.2 GSK
    • 4.2.1 GSK Corporation Information
    • 4.2.2 GSK Description, Business Overview
    • 4.2.3 GSK Eosinophilic Esophagitis Drug Products Offered
    • 4.2.4 GSK Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
    • 4.2.5 GSK Eosinophilic Esophagitis Drug Revenue by Product
    • 4.2.6 GSK Eosinophilic Esophagitis Drug Revenue by Application
    • 4.2.7 GSK Eosinophilic Esophagitis Drug Revenue by Geographic Area
    • 4.2.8 GSK Eosinophilic Esophagitis Drug Revenue by Sales Channel
    • 4.2.9 GSK Recent Development
  • 4.3 Bayer
    • 4.3.1 Bayer Corporation Information
    • 4.3.2 Bayer Description, Business Overview
    • 4.3.3 Bayer Eosinophilic Esophagitis Drug Products Offered
    • 4.3.4 Bayer Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
    • 4.3.5 Bayer Eosinophilic Esophagitis Drug Revenue by Product
    • 4.3.6 Bayer Eosinophilic Esophagitis Drug Revenue by Application
    • 4.3.7 Bayer Eosinophilic Esophagitis Drug Revenue by Geographic Area
    • 4.3.8 Bayer Eosinophilic Esophagitis Drug Revenue by Sales Channel
    • 4.3.9 Bayer Recent Development
  • 4.4 Adare Pharmaceuticals
    • 4.4.1 Adare Pharmaceuticals Corporation Information
    • 4.4.2 Adare Pharmaceuticals Description, Business Overview
    • 4.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Products Offered
    • 4.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
    • 4.4.5 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue by Product
    • 4.4.6 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue by Application
    • 4.4.7 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue by Geographic Area
    • 4.4.8 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue by Sales Channel
    • 4.4.9 Adare Pharmaceuticals Recent Development
  • 4.5 DBV Technologies
    • 4.5.1 DBV Technologies Corporation Information
    • 4.5.2 DBV Technologies Description, Business Overview
    • 4.5.3 DBV Technologies Eosinophilic Esophagitis Drug Products Offered
    • 4.5.4 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
    • 4.5.5 DBV Technologies Eosinophilic Esophagitis Drug Revenue by Product
    • 4.5.6 DBV Technologies Eosinophilic Esophagitis Drug Revenue by Application
    • 4.5.7 DBV Technologies Eosinophilic Esophagitis Drug Revenue by Geographic Area
    • 4.5.8 DBV Technologies Eosinophilic Esophagitis Drug Revenue by Sales Channel
    • 4.5.9 DBV Technologies Recent Development
  • 4.6 Dr. Falk Pharma
    • 4.6.1 Dr. Falk Pharma Corporation Information
    • 4.6.2 Dr. Falk Pharma Description, Business Overview
    • 4.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Products Offered
    • 4.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
    • 4.6.5 Dr. Falk Pharma Eosinophilic Esophagitis Drug Revenue by Product
    • 4.6.6 Dr. Falk Pharma Eosinophilic Esophagitis Drug Revenue by Application
    • 4.6.7 Dr. Falk Pharma Eosinophilic Esophagitis Drug Revenue by Geographic Area
    • 4.6.8 Dr. Falk Pharma Recent Development
  • 4.7 Quorum Innovations
    • 4.7.1 Quorum Innovations Corporation Information
    • 4.7.2 Quorum Innovations Description, Business Overview
    • 4.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Products Offered
    • 4.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
    • 4.7.5 Quorum Innovations Eosinophilic Esophagitis Drug Revenue by Product
    • 4.7.6 Quorum Innovations Eosinophilic Esophagitis Drug Revenue by Application
    • 4.7.7 Quorum Innovations Eosinophilic Esophagitis Drug Revenue by Geographic Area
    • 4.7.8 Quorum Innovations Recent Development
  • 4.8 Takeda
    • 4.8.1 Takeda Corporation Information
    • 4.8.2 Takeda Description, Business Overview
    • 4.8.3 Takeda Eosinophilic Esophagitis Drug Products Offered
    • 4.8.4 Takeda Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
    • 4.8.5 Takeda Eosinophilic Esophagitis Drug Revenue by Product
    • 4.8.6 Takeda Eosinophilic Esophagitis Drug Revenue by Application
    • 4.8.7 Takeda Eosinophilic Esophagitis Drug Revenue by Geographic Area
    • 4.8.8 Takeda Recent Development
  • 4.9 Calypso
    • 4.9.1 Calypso Corporation Information
    • 4.9.2 Calypso Description, Business Overview
    • 4.9.3 Calypso Eosinophilic Esophagitis Drug Products Offered
    • 4.9.4 Calypso Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
    • 4.9.5 Calypso Eosinophilic Esophagitis Drug Revenue by Product
    • 4.9.6 Calypso Eosinophilic Esophagitis Drug Revenue by Application
    • 4.9.7 Calypso Eosinophilic Esophagitis Drug Revenue by Geographic Area
    • 4.9.8 Calypso Recent Development
  • 4.10 Celgene
    • 4.10.1 Celgene Corporation Information
    • 4.10.2 Celgene Description, Business Overview
    • 4.10.3 Celgene Eosinophilic Esophagitis Drug Products Offered
    • 4.10.4 Celgene Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
    • 4.10.5 Celgene Eosinophilic Esophagitis Drug Revenue by Product
    • 4.10.6 Celgene Eosinophilic Esophagitis Drug Revenue by Application
    • 4.10.7 Celgene Eosinophilic Esophagitis Drug Revenue by Geographic Area
    • 4.10.8 Celgene Recent Development
  • 4.11 Regeneron
    • 4.11.1 Regeneron Corporation Information
    • 4.11.2 Regeneron Description, Business Overview
    • 4.11.3 Regeneron Eosinophilic Esophagitis Drug Products Offered
    • 4.11.4 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
    • 4.11.5 Regeneron Eosinophilic Esophagitis Drug Revenue by Product
    • 4.11.6 Regeneron Eosinophilic Esophagitis Drug Revenue by Application
    • 4.11.7 Regeneron Eosinophilic Esophagitis Drug Revenue by Geographic Area
    • 4.11.8 Regeneron Recent Development

5 Breakdown Data by Type

  • 5.1 Global Eosinophilic Esophagitis Drug Sales by Type (2015-2026)
    • 5.1.1 Global Eosinophilic Esophagitis Drug Sales by Type (2015-2020)
    • 5.1.2 Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2021-2026)
    • 5.1.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2026)
  • 5.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2015-2026)
    • 5.2.1 Global Eosinophilic Esophagitis Drug Revenue by Type (2015-2020)
    • 5.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2021-2026)
    • 5.2.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2015-2026)
  • 5.3 Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Type (2015-2026)

6 Breakdown Data by Application

  • 6.1 Global Eosinophilic Esophagitis Drug Sales by Application (2015-2026)
    • 6.1.1 Global Eosinophilic Esophagitis Drug Sales by Application (2015-2020)
    • 6.1.2 Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2021-2026)
    • 6.1.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2026)
  • 6.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2015-2026)
    • 6.2.1 Global Eosinophilic Esophagitis Drug Revenue by Application (2015-2020)
    • 6.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2021-2026)
    • 6.2.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2015-2026)
  • 6.3 Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Application (2015-2026)

7 North America

  • 7.1 North America Eosinophilic Esophagitis Drug Market Size YoY Growth 2015-2026
  • 7.2 North America Eosinophilic Esophagitis Drug Market Facts & Figures by Country
    • 7.2.1 North America Eosinophilic Esophagitis Drug Sales by Country (2015-2026)
    • 7.2.2 North America Eosinophilic Esophagitis Drug Revenue by Country (2015-2026)
  • 7.3 North America Eosinophilic Esophagitis Drug Sales by Type
  • 7.4 North America Eosinophilic Esophagitis Drug Sales by Application

8 Asia-Pacific

  • 8.1 Asia-Pacific Eosinophilic Esophagitis Drug Market Size YoY Growth 2015-2026
  • 8.2 Asia-Pacific Eosinophilic Esophagitis Drug Market Facts & Figures by Region
    • 8.2.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2015-2026)
    • 8.2.2 Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Region (2015-2026)
  • 8.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type
  • 8.4 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application

9 Europe

  • 9.1 Europe Eosinophilic Esophagitis Drug Market Size YoY Growth 2015-2026
  • 9.2 Europe Eosinophilic Esophagitis Drug Market Facts & Figures by Country
    • 9.2.1 Europe Eosinophilic Esophagitis Drug Sales by Country (2015-2026)
    • 9.2.2 Europe Eosinophilic Esophagitis Drug Revenue by Country (2015-2026)
  • 9.3 Europe Eosinophilic Esophagitis Drug Sales by Type
  • 9.4 Europe Eosinophilic Esophagitis Drug Sales by Application

10 Latin America

  • 10.1 Latin America Eosinophilic Esophagitis Drug Market Size YoY Growth 2015-2026
  • 10.2 Latin America Eosinophilic Esophagitis Drug Market Facts & Figures by Country
    • 10.2.1 Latin America Eosinophilic Esophagitis Drug Sales by Country (2015-2026)
    • 10.2.2 Latin America Eosinophilic Esophagitis Drug Revenue by Country (2015-2026)
  • 10.3 Latin America Eosinophilic Esophagitis Drug Sales by Type
  • 10.4 Latin America Eosinophilic Esophagitis Drug Sales by Application

11 Middle East and Africa

  • 11.1 Middle East and Africa Eosinophilic Esophagitis Drug Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Eosinophilic Esophagitis Drug Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2015-2026)
    • 11.2.2 Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2015-2026)
  • 11.3 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type
  • 11.4 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application

12 Supply Chain and Sales Channel Analysis

  • 12.1 Eosinophilic Esophagitis Drug Supply Chain Analysis
  • 12.2 Eosinophilic Esophagitis Drug Key Raw Materials and Upstream Suppliers
  • 12.3 Eosinophilic Esophagitis Drug Clients Analysis
  • 12.4 Eosinophilic Esophagitis Drug Sales Channel and Sales Model Analysis
    • 12.4.1 Eosinophilic Esophagitis Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
    • 12.4.2 Eosinophilic Esophagitis Drug Distribution Channel Analysis: Online Sales VS Offline Sales
    • 12.4.3 Eosinophilic Esophagitis Drug Distributors

13 Market Dynamics

  • 13.1 Eosinophilic Esophagitis Drug Market Drivers
  • 13.2 Eosinophilic Esophagitis Drug Market Opportunities
  • 13.3 Eosinophilic Esophagitis Drug Market Challenges
  • 13.4 Eosinophilic Esophagitis Drug Market Restraints
  • 13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Eosinophilic Esophagitis Drug market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Eosinophilic Esophagitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

    Segment by Type, the Eosinophilic Esophagitis Drug market is segmented into
    Budesonide
    Fluticasone
    Others

    Segment by Application, the Eosinophilic Esophagitis Drug market is segmented into
    Hospitals
    Clinics
    Drugstore

    Regional and Country-level Analysis:
    North America
    United States
    Canada
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Southeast Asia
    Australia
    Rest of Asia-Pacific
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic Countries
    Rest of Europe
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    Competitive Landscape and Eosinophilic Esophagitis Drug Market Share Analysis
    Eosinophilic Esophagitis Drug market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Eosinophilic Esophagitis Drug product introduction, recent developments, Eosinophilic Esophagitis Drug sales by region, type, application and by sales channel.

    The major companies include:
    AstraZeneca
    GSK
    Bayer
    Adare Pharmaceuticals
    DBV Technologies
    Dr. Falk Pharma
    Quorum Innovations
    Takeda
    Calypso
    Celgene
    Regeneron

    Buy now